Calcitriol and its analogs such as paricalcitol (19-nor-1α,25(OH)2D2) that activate vitamin D receptor (VDR) are commonly used to manage hyperparathyroidism secondary to CKD [13]. Here, VDR is linked to chronic kidney disease.